Literature DB >> 2841478

Gene product of region E4 of adenovirus type 5 modulates accumulation of certain viral polypeptides.

C Hemström1, K Nordqvist, U Pettersson, A Virtanen.   

Abstract

An adenovirus type 5 mutant, designated H5ilE4I, was constructed in which region E4 was replaced by a cloned cDNA. The cDNA was a copy of an mRNA which exclusively contains open translational reading frames 6 and 7. The phenotype of the mutant was compared with that of the previously characterized E4 mutant H2dl808 and wild-type adenovirus 5. Although the H5ilE4I mutant lacked at least five E4 genes, it was nondefective for growth in HeLa cells. The defects in viral DNA replication, late protein synthesis, and shutoff of host cell protein synthesis associated with the phenotype of the H2dl808 mutant were not observed in HeLa cells infected with the H5ilE4I mutant. However, differences were observed regarding the time of onset of viral DNA replication and the accumulation of the hexon polypeptide as well as the 72-kilodalton adenovirus-specific DNA-binding protein. The results thus indicate that open reading frame 6 or 7 or both contain all genetic information required for viral replication in tissue culture cells, whereas another E4 gene modulates the accumulation of certain viral polypeptides. The early onset of viral DNA replication in H5ilE4I-infected cells may be an indirect effect of the enhanced expression of the 72-kilodalton DNA-binding protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841478      PMCID: PMC253445          DOI: 10.1128/JVI.62.9.3258-3264.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  33 in total

1.  A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase.

Authors:  F Sanger; A R Coulson
Journal:  J Mol Biol       Date:  1975-05-25       Impact factor: 5.469

2.  Mapping of adenovirus 2 RNA sequences in lytically infected cells and transformed cell lines.

Authors:  P A Sharp; P H Gallimore; S J Flint
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Hybridization maps of early and late messenger RNA sequences on the adenovirus type 2 genome.

Authors:  U Pettersson; C Tibbetts; L Philipson
Journal:  J Mol Biol       Date:  1976-03-15       Impact factor: 5.469

4.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

5.  Adenovirus assay by the fluorescent cell-counting procedure.

Authors:  L PHILIPSON
Journal:  Virology       Date:  1961-11       Impact factor: 3.616

6.  A map of cytoplasmic RNA transcripts from lytic adenovirus type 2, determined by electron microscopy of RNA:DNA hybrids.

Authors:  L T Chow; J M Roberts; J B Lewis; T R Broker
Journal:  Cell       Date:  1977-08       Impact factor: 41.582

7.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

8.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

9.  A procedure for the isolation of mammalian messenger ribonucleic acid.

Authors:  G Brawerman; J Mendecki; S Y Lee
Journal:  Biochemistry       Date:  1972-02-15       Impact factor: 3.162

10.  Purification and characterization of the phosphorylated DNA-binding protein from adenovirus-type-2-infected cells.

Authors:  T Linné; H Jörnvall; L Philipson
Journal:  Eur J Biochem       Date:  1977-06-15
View more
  13 in total

1.  Defective synthesis of early region 4 mRNAs during abortive adenovirus infections in monkey cells.

Authors:  D Ross; E Ziff
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

2.  Adenovirus early region 4 stimulates mRNA accumulation via 5' introns.

Authors:  K Nordqvist; G Akusjärvi
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  The adenovirus E4 17-kilodalton protein complexes with the cellular transcription factor E2F, altering its DNA-binding properties and stimulating E1A-independent accumulation of E2 mRNA.

Authors:  M J Marton; S B Baim; D A Ornelles; T Shenk
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

4.  A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.

Authors:  D E Brough; A Lizonova; C Hsu; V A Kulesa; I Kovesdi
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

5.  Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses.

Authors:  J F Dedieu; E Vigne; C Torrent; C Jullien; I Mahfouz; J M Caillaud; N Aubailly; C Orsini; J M Guillaume; P Opolon; P Delaere; M Perricaudet; P Yeh
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids.

Authors:  G Ketner; E Bridge; A Virtanen; C Hemström; U Pettersson
Journal:  Nucleic Acids Res       Date:  1989-04-25       Impact factor: 16.971

7.  Human adenovirus type 5 variants with sequence alterations flanking the E2A gene: effects on E2 expression and DNA replication.

Authors:  C Caravokyri; K N Leppard
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

8.  Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs.

Authors:  K Nordqvist; K Ohman; G Akusjärvi
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

9.  Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection.

Authors:  M M Huang; P Hearing
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

10.  Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit.

Authors:  P Yeh; J F Dedieu; C Orsini; E Vigne; P Denefle; M Perricaudet
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.